- Exchange: Berlin
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Amarillo Biosciences Inc+ Add to Watchlist
FZX:GR0.005 EUR 0.0000.00%
As of 08:13:40 ET on 03/10/2014.
Company Profile for Amarillo Biosciences Inc (FZX)
Amarillo Biosciences, Inc. develops biologics for the treatment of human and animal diseases. The Company develops oral interferon alpha as a treatment for a variety of conditions, including Sjogren's syndrome, hepatitis B and C, and fibromyalgia syndrome.
Amarillo Biosciences Inc
Key Executives for Amarillo Biosciences Inc (FZX)
|Stephen T ChenChairman/CEO||Joseph M CumminsPresident/COO/Founder|